These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 17855570

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
    Mitarai S, Kobayashi I, Abe C, Wada M, Suzuki K, Takashima T, Kawabe Y, Machida K, Tano M, Takigawa S, Kamada A, Shigetoh E, Fujii S, Mori K, Suyama H, Yano S, Kawashiro T, Ogata H.
    Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123
    [Abstract] [Full Text] [Related]

  • 23. Drug susceptibility testing of Mycobacterium tuberculosis to fluoroquinolones: first experience with a quality control panel in the Nordic-Baltic collaboration.
    Johansen IS, Larsen AR, Sandven P, Petrini B, Soini H, Levina K, Sosnovskaja A, Skenders G, Hoffner S.
    Int J Tuberc Lung Dis; 2003 Sep; 7(9):899-902. PubMed ID: 12971676
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.
    Van Deun A, Wright A, Zignol M, Weyer K, Rieder HL.
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):116-24. PubMed ID: 21276307
    [Abstract] [Full Text] [Related]

  • 26. [Comparative study of 3 tests for susceptibility of Mycobacterium tuberculosis to first-line antituberculous drugs].
    Delás MA, Martínez C, Yagüe C, Rodríguez T, Rodríguez T, Segovia M.
    Rev Esp Quimioter; 2001 Mar; 14(1):40-6. PubMed ID: 11376348
    [Abstract] [Full Text] [Related]

  • 27. First proficiency testing of second-line anti-tuberculosis drug susceptibility testing in 12 provinces of China.
    Jiang GL, Chen X, Song Y, Zhao Y, Huang H, Kam KM.
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1491-4. PubMed ID: 24125456
    [Abstract] [Full Text] [Related]

  • 28. Rapid detection of resistant tuberculosis by nitrate reductase assay performed in three settings in Brazil.
    Shikama Mde L, Silva RR, Martins MC, Giampaglia CM, Oliveira RS, Silva RF, Silva PF, Telles MA, Martin A, Palomino JC.
    J Antimicrob Chemother; 2009 Oct; 64(4):794-6. PubMed ID: 19671589
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
    Schön T, Juréen P, Giske CG, Chryssanthou E, Sturegård E, Werngren J, Kahlmeter G, Hoffner SE, Angeby KA.
    J Antimicrob Chemother; 2009 Oct; 64(4):786-93. PubMed ID: 19633001
    [Abstract] [Full Text] [Related]

  • 30. Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan, 2007-2011.
    Wu MH, Chiang CY, Deng YM, Wang TF, Jou R.
    Int J Tuberc Lung Dis; 2013 Jan; 17(1):113-9. PubMed ID: 23232011
    [Abstract] [Full Text] [Related]

  • 31. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
    Garrigó M, Aragón LM, Alcaide F, Borrell S, Cardeñosa E, Galán JJ, Gonzalez-Martín J, Martin-Casabona N, Moreno C, Salvado M, Coll P.
    J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA.
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [Abstract] [Full Text] [Related]

  • 34. [Resistance rates to antituberculous drugs in Sivas province].
    Gönlügür U, Bakici MZ, Gönlügür TE, Hasbek M.
    Mikrobiyol Bul; 2007 Jul; 41(3):459-63. PubMed ID: 17933259
    [Abstract] [Full Text] [Related]

  • 35. External quality control of phenotypic drug susceptibility testing for Mycobacterium tuberculosis in China.
    Shu W, Du J, Liu Y, Wang Y, Huo F, Jiang G, Li L, Pang Y.
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):871-875. PubMed ID: 31898799
    [Abstract] [Full Text] [Related]

  • 36. In vitro susceptibility testing of Mycobacterium tuberculosis complex strains isolated from seals to antituberculosis drugs.
    Bernardelli A, Morcillo N, Loureiro J, Quse V, Davenport S.
    Biomedica; 2004 Jun; 24 Supp 1():85-91. PubMed ID: 15495576
    [Abstract] [Full Text] [Related]

  • 37. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
    Hartkoorn RC, Chandler B, Owen A, Ward SA, Bertel Squire S, Back DJ, Khoo SH.
    Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938
    [Abstract] [Full Text] [Related]

  • 38. [Drug susceptibility testing for M. tuberculosis with proportion method].
    Liu Y, Wang S, Na X.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Feb; 23(2):89-92. PubMed ID: 11778497
    [Abstract] [Full Text] [Related]

  • 39. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
    Robledo J, Mejia GI, Paniagua L, Martin A, Guzmán A.
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1482-4. PubMed ID: 19017461
    [Abstract] [Full Text] [Related]

  • 40. [Comparison of susceptibility testing results of M. tuberculosis by different methods].
    Ding B, Zhao T, Gai Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul; 23(7):423-5. PubMed ID: 11778510
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.